You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ceralasertib

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumours Trial in Beijing (Ceralasertib, Durvalumab)

Not yet recruiting
  • Advanced Solid Tumours
  • Beijing, China
    Research Site
Aug 23, 2022

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Ceralasertib
  • +2 more
  • Milano, Italy
  • +1 more
Jan 16, 2023

Advanced Solid Malignancies Trial in Chuo-ku (Ceralasertib)

Recruiting
  • Advanced Solid Malignancies
  • Ceralasertib
  • Chuo-ku, Japan
    Research Site
Jul 20, 2022

Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)

Recruiting
  • Advanced or Metastatic NSCLC
  • Moscow, Russian Federation
  • +7 more
Jul 4, 2023

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

Recruiting
  • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
  • Administration of ceralasertib in combination with carboplatin
  • +3 more
  • Duarte, California
  • +26 more
Aug 17, 2022

Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Biopsy
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 29, 2022

Melanoma Trial in Worldwide (Ceralasertib, Durvalumab)

Recruiting
  • Melanoma
  • Ceralasertib
  • Durvalumab
  • Los Angeles, California
  • +75 more
Dec 5, 2022

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Kraków, Poland
  • +10 more
Dec 2, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Advanced or Metastatic NSCLC Trial (Ceralasertib, Durvalumab, Docetaxel)

Recruiting
  • Advanced or Metastatic Non-Small Cell Lung Cancer
  • Ceralasertib
  • +2 more
  • Chandler, Arizona
  • +80 more
Jan 12, 2023

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Head and Neck Squamous Cell Carcinoma Trial in France, Taiwan, United States (Ceralasertib, Olaparib)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
  • +3 more
Aug 9, 2021

Advanced Solid Tumours Trial in France, Spain, United States (Ceralasertib)

Recruiting
  • Advanced Solid Tumours
  • Ceralasertib
  • Tucson, Arizona
  • +31 more
Jan 13, 2023

Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

Active, not recruiting
Has Results
  • Metastatic Triple Negative Breast Cancer
  • Olaparib Continuous (28-Day cycle) 300 mg BD.
  • +2 more
  • Birmingham, Alabama
  • +140 more
Nov 17, 2022

Ovarian Cancer Trial in Worldwide (Olaparib, Ceralasertib, Placebo to match olaparib)

Withdrawn
  • Ovarian Cancer
  • Anchorage, Alaska
  • +25 more
Mar 9, 2021